These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 20534250)

  • 1. The contraceptive vaginal ring in women with renal and liver transplantation: analysis of preliminary results.
    Paternoster DM; Riboni F; Bertolino M; Garofalo G; Lazzarich E; Surico N; Stratta P
    Transplant Proc; 2010 May; 42(4):1162-5. PubMed ID: 20534250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An open-label, multicentre trial to evaluate the vaginal bleeding pattern of the combined contraceptive vaginal ring NuvaRing.
    Bruni V; Pontello V; Luisi S; Petraglia F
    Eur J Obstet Gynecol Reprod Biol; 2008 Jul; 139(1):65-71. PubMed ID: 18358586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contraceptive efficacy and tolerability with a novel combined contraceptive vaginal ring, NuvaRing.
    Roumen F
    Eur J Contracept Reprod Health Care; 2002 Dec; 7 Suppl 2():19-24; discussion 37-9. PubMed ID: 12659398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lower hormone dosage with improved cycle control.
    Vree M
    Eur J Contracept Reprod Health Care; 2002 Dec; 7 Suppl 2():25-30; discussion 37-9. PubMed ID: 12659399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral and transdermal hormonal contraception in women after kidney transplantation.
    Pietrzak B; Bobrowska K; Jabiry-Zieniewicz Z; Kaminski P; Wielgos M; Pazik J; Durlik M
    Transplant Proc; 2007 Nov; 39(9):2759-62. PubMed ID: 18021980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bleeding patterns of women using extended regimens of the contraceptive vaginal ring.
    Barreiros FA; Guazzelli CA; de Araújo FF; Barbosa R
    Contraception; 2007 Mar; 75(3):204-8. PubMed ID: 17303490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extended regimens of the vaginal contraceptive ring: cycle control.
    Guazzelli CA; Barreiros FA; Barbosa R; de Araújo FF; Moron AF
    Contraception; 2009 Nov; 80(5):430-5. PubMed ID: 19835716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extended regimens of the contraceptive vaginal ring: a randomized trial.
    Miller L; Verhoeven CH; Hout Ji
    Obstet Gynecol; 2005 Sep; 106(3):473-82. PubMed ID: 16135576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High acceptability and satisfaction with NuvaRing use.
    Szarewski A
    Eur J Contracept Reprod Health Care; 2002 Dec; 7 Suppl 2():31-6; discussion 37-9. PubMed ID: 12659400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The contraceptive vaginal ring.
    Edwardson J; Jamshidi R
    Semin Reprod Med; 2010 Mar; 28(2):133-9. PubMed ID: 20352563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The combined contraceptive vaginal device (NuvaRing): a comprehensive review.
    Sarkar NN
    Eur J Contracept Reprod Health Care; 2005 Jun; 10(2):73-8. PubMed ID: 16147810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The combined contraceptive vaginal ring, NuvaRing, and tampon co-usage.
    Verhoeven CH; Dieben TO
    Contraception; 2004 Mar; 69(3):197-9. PubMed ID: 14969666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cycle control, tolerability, efficacy and acceptability of the vaginal contraceptive ring, NuvaRing: results of clinical experience in Germany.
    Brucker C; Karck U; Merkle E
    Eur J Contracept Reprod Health Care; 2008 Mar; 13(1):31-8. PubMed ID: 17853162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ethinylestradiol + etonogestrel contraceptive vaginal ring: new drug. Possibly useful in some situations.
    Prescrire Int; 2006 Apr; 15(82):50-3. PubMed ID: 16604729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contraceptive vaginal rings releasing Nestorone and ethinylestradiol: a 1-year dose-finding trial.
    Sivin I; Mishell DR; Alvarez F; Brache V; Elomaa K; Lähteenmäki P; Massai R; Miranda P; Croxatto H; Dean C; Small M; Nash H; Jackanicz TM
    Contraception; 2005 Feb; 71(2):122-9. PubMed ID: 15707562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Superior cycle control with a contraceptive vaginal ring compared with an oral contraceptive containing 30 microg ethinylestradiol and 150 microg levonorgestrel: a randomized trial.
    Oddsson K; Leifels-Fischer B; Wiel-Masson D; de Melo NR; Benedetto C; Verhoeven CH; Dieben TO
    Hum Reprod; 2005 Feb; 20(2):557-62. PubMed ID: 15539438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of a contraceptive vaginal ring (NuvaRing) compared with a combined oral contraceptive: a 1-year randomized trial.
    Oddsson K; Leifels-Fischer B; de Melo NR; Wiel-Masson D; Benedetto C; Verhoeven CH; Dieben TO
    Contraception; 2005 Mar; 71(3):176-82. PubMed ID: 15722066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The vaginal contraceptive pill.
    Coutinho E
    IPPF Med Bull; 1985 Feb; 19(1):2-3. PubMed ID: 12339969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Contraception in the hypertensive woman using a vaginal ring delivering estradiol and norgestrel].
    Elkik F; Basdevant A; Corvol P
    Arch Mal Coeur Vaiss; 1985 Oct; 78(11):1737-9. PubMed ID: 3938250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical experience with the combined contraceptive vaginal ring in Switzerland, including a subgroup analysis of previous hormonal contraceptive use.
    Merki-Feld GS; Hund M
    Eur J Contracept Reprod Health Care; 2010 Dec; 15(6):413-22. PubMed ID: 21028953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.